PDP III – Product development for tuberculosis drug regimens

This project was implemented under the PDP III programme by the Global Alliance for TB Drug Development (TB Alliance).

The TB Alliance's mission is to dramatically impact the tuberculosis (TB) pandemic by developing new, significantly improved, faster-acting and affordable TB treatments that are available to those who need them.

PDP15US01
Good Health and Well-being

Project number

NL-KVK-27378529-PDP15US01

Total budget

€ 18,360,000

Countries

Brazil, Kenya, Malaysia, Mozambique, Peru, South Africa

Project status

Finalised

Budget spent

100.00 %
100.00 % spent

Tied status

Untied
Startdate:
Enddate:

Project partners

Global Alliance for TB Drug Development (TB Alliance), Netherlands Enterprise Agency

Sectors

Tuberculosis control
Transactions
TypeProviderProvider ref.ReceiverReceiver ref.Value (€)DateValue date
Incoming Funds 15,300,000.00 16-10-2015 16-10-2015
Incoming Funds 3,060,000.00 29-01-2021 29-01-2021
Outgoing Commitment Global Alliance for TB Drug Development (TB Alliance) 15,300,000.00 16-10-2015 16-10-2015
Outgoing Commitment Global Alliance for TB Drug Development (TB Alliance) 3,060,000.00 29-01-2021 29-01-2021
Disbursement Global Alliance for TB Drug Development (TB Alliance) 1,530,000.00 19-01-2016 19-01-2016
Disbursement Global Alliance for TB Drug Development (TB Alliance) 1,530,000.00 11-07-2016 11-07-2016
Disbursement Global Alliance for TB Drug Development (TB Alliance) 1,530,000.00 20-02-2017 20-02-2017
Disbursement Global Alliance for TB Drug Development (TB Alliance) 1,530,000.00 13-07-2017 13-07-2017
Disbursement Global Alliance for TB Drug Development (TB Alliance) 1,530,000.00 30-01-2018 30-01-2018
Disbursement Global Alliance for TB Drug Development (TB Alliance) 1,530,000.00 18-07-2018 18-07-2018
Disbursement Global Alliance for TB Drug Development (TB Alliance) 1,530,000.00 01-02-2019 01-02-2019
Disbursement Global Alliance for TB Drug Development (TB Alliance) 1,530,000.00 04-07-2019 04-07-2019
Disbursement Global Alliance for TB Drug Development (TB Alliance) 1,147,500.00 06-03-2020 06-03-2020
Disbursement Global Alliance for TB Drug Development (TB Alliance) 1,147,500.00 09-07-2020 09-07-2020
Disbursement Global Alliance for TB Drug Development (TB Alliance) 2,907,000.00 11-02-2021 11-02-2021
Disbursement Global Alliance for TB Drug Development (TB Alliance) 765,000.00 19-01-2022 19-01-2022
Disbursement Global Alliance for TB Drug Development (TB Alliance) 153,000.00 20-10-2022 20-10-2022